$6.87
-0.22 (-3.10%)
Performance
1D
+0.15%
1W
+1.18%
1M
-42.65%
3M
-40.36%
6M
-42.07%
1Y
-63.84%
YTD
-63.84%
Open$7.19
Previous Close$7.09
Day High$7.55
Day Low$6.81
52W High$19.95
52W Low$6.42
Volume—
Avg Volume1.34M
Market Cap888.97M
P/E Ratio3.66
EPS$10.37
SectorN/A
Technical Indicators
Full analysis →
SMA 50
$10.33
Below
RSI (14)
16.5
Oversold
Analyst Ratings
Strong Buy
13 analysts
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.99B | 1.52B | 1.25B |
| Net Income | 1.09B | 748.22M | 76.97M |
| Profit Margin | 54.8% | 52.1% | 6.2% |
| EBITDA | -3,156,117,367 | -2,287,041,570 | 127.47M |
| Free Cash Flow | — | — | 81.25M |
| Rev Growth | +31.1% | +31.1% | -0.7% |
| Debt/Equity | 7.75 | 7.75 | 0.17 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $1.96 | +2.62% | — | 1.23B |
| DMII | Drugs Made In America Acquis | $10.22 | -0.05% | 50.0 | 651.01M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.59 | +0.00% | 27.6 | 219.04M |
| CEPF | Cantor Equity Partners-Cl A | $10.32 | -0.10% | 41.5 | 589.79M |
| BCSS | Bain Capital Gss Inv- A | $10.22 | +0.05% | 48.7 | 597.72M |